Drug treatment for systemic skin cancer

The treatment of skin cancer has always been a big problem that troubles many patients. Since the symptoms of skin cancer are not very obvious and the initial pain is not very strong, many patients do not pay much attention to the treatment of skin cancer. Here, we will talk about some things to pay attention to when using drugs to treat skin cancer .

(1) Indications: Systemic chemotherapy is required for the treatment of squamous cell carcinoma that occurs on the basis of existing scars, squamous cell carcinoma at the junction of the skin and mucosa, patients with impaired immune function, and those with regional lymph node and distant metastasis.

(2) BLM is more effective for outward-proliferating squamous cell carcinoma. The administration method is intramuscular or intravenous injection. The specific dosage needs to be analyzed based on the patient's condition. Skin cancer treatment should be carried out under the doctor's advice.

(3) PEP (petomycin): It is not only sensitive to primary lesions, but also has an efficacy of about 30% for cases with lymph node metastasis. Usage: 5 mg once, 6 times a week, intramuscular injection, stop for 1 day, repeat 5 to 7 times.

(4) Combined use of DDP and ADM: The chemotherapy method is intravenous drip of DDP 75mg/m2, combined with hydration, that is, large-scale infusion and diuretics, ADM 50mg + 40ml of injection water are injected within 5 minutes. After a 3-week interval, all patients received adequate chemotherapy, and the remission rate during chemotherapy was 87%.

There are many treatments for skin cancer. With the development of medical technology, many new treatments are emerging, making skin cancer no longer an incurable disease. If you have any questions about the treatment of skin cancer, please consult our online experts.